Adam Scott Landsman, D.P.M., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Foot | 18 | 2023 | 382 | 3.730 |
Why?
|
| Varicose Ulcer | 3 | 2023 | 55 | 2.110 |
Why?
|
| Skin, Artificial | 6 | 2023 | 89 | 2.100 |
Why?
|
| Wound Healing | 17 | 2023 | 2800 | 1.890 |
Why?
|
| Podiatry | 4 | 2023 | 28 | 1.110 |
Why?
|
| Arthroplasty | 3 | 2018 | 308 | 1.050 |
Why?
|
| Metatarsal Bones | 8 | 2009 | 111 | 0.960 |
Why?
|
| Arthralgia | 3 | 2018 | 459 | 0.940 |
Why?
|
| Foot Ulcer | 4 | 2018 | 62 | 0.940 |
Why?
|
| Surgical Flaps | 8 | 2018 | 1680 | 0.860 |
Why?
|
| Foot Deformities | 4 | 2011 | 35 | 0.850 |
Why?
|
| Skin Transplantation | 2 | 2020 | 1097 | 0.830 |
Why?
|
| Foot Joints | 2 | 2018 | 34 | 0.820 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2023 | 123 | 0.810 |
Why?
|
| Heel | 3 | 2013 | 38 | 0.800 |
Why?
|
| Foot Dermatoses | 3 | 2012 | 46 | 0.800 |
Why?
|
| Onychomycosis | 3 | 2012 | 50 | 0.790 |
Why?
|
| Insurance | 1 | 2023 | 115 | 0.760 |
Why?
|
| Industry | 1 | 2023 | 362 | 0.740 |
Why?
|
| Foot Injuries | 2 | 2018 | 154 | 0.720 |
Why?
|
| Fasciitis, Plantar | 2 | 2013 | 41 | 0.710 |
Why?
|
| Leg Ulcer | 2 | 2010 | 71 | 0.690 |
Why?
|
| Collagen | 3 | 2018 | 2636 | 0.690 |
Why?
|
| Hallux Rigidus | 2 | 2018 | 13 | 0.660 |
Why?
|
| Arthropathy, Neurogenic | 4 | 2009 | 29 | 0.650 |
Why?
|
| Calcaneus | 3 | 2019 | 144 | 0.640 |
Why?
|
| Tendons | 4 | 2020 | 556 | 0.630 |
Why?
|
| Hallux Limitus | 1 | 2018 | 2 | 0.620 |
Why?
|
| Intra-Articular Fractures | 1 | 2019 | 73 | 0.600 |
Why?
|
| Polyurethanes | 1 | 2018 | 110 | 0.570 |
Why?
|
| Biocompatible Materials | 5 | 2018 | 1690 | 0.540 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2020 | 749 | 0.530 |
Why?
|
| Foot | 9 | 2015 | 576 | 0.530 |
Why?
|
| Ankle Joint | 3 | 2018 | 452 | 0.530 |
Why?
|
| Achilles Tendon | 1 | 2018 | 181 | 0.500 |
Why?
|
| Wounds and Injuries | 2 | 2020 | 2513 | 0.500 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 484 | 0.490 |
Why?
|
| Tendinopathy | 1 | 2018 | 174 | 0.490 |
Why?
|
| Toes | 3 | 2004 | 209 | 0.470 |
Why?
|
| Bandages | 2 | 2019 | 271 | 0.440 |
Why?
|
| Orthotic Devices | 2 | 2009 | 131 | 0.430 |
Why?
|
| Cryopreservation | 2 | 2016 | 727 | 0.430 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 505 | 0.420 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 982 | 0.390 |
Why?
|
| Foot Diseases | 3 | 2009 | 148 | 0.390 |
Why?
|
| Ofloxacin | 1 | 2011 | 66 | 0.380 |
Why?
|
| Osteomyelitis | 3 | 2004 | 408 | 0.380 |
Why?
|
| Toe Joint | 2 | 2016 | 19 | 0.370 |
Why?
|
| Metatarsophalangeal Joint | 3 | 2009 | 41 | 0.360 |
Why?
|
| Internal Fixators | 5 | 2009 | 183 | 0.360 |
Why?
|
| Lasers, Semiconductor | 1 | 2010 | 44 | 0.340 |
Why?
|
| Salvage Therapy | 3 | 2004 | 1271 | 0.330 |
Why?
|
| Tibial Nerve | 1 | 2009 | 55 | 0.330 |
Why?
|
| Ligaments | 2 | 2009 | 127 | 0.320 |
Why?
|
| Wound Infection | 1 | 2011 | 244 | 0.320 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2010 | 254 | 0.300 |
Why?
|
| Hallux Valgus | 3 | 2005 | 67 | 0.300 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2010 | 156 | 0.300 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 740 | 0.300 |
Why?
|
| Osteotomy | 6 | 2009 | 837 | 0.290 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2010 | 616 | 0.290 |
Why?
|
| Catheter Ablation | 2 | 2013 | 2787 | 0.290 |
Why?
|
| Tendon Transfer | 1 | 2008 | 125 | 0.280 |
Why?
|
| Oxygen | 1 | 2018 | 4252 | 0.260 |
Why?
|
| Orthopedic Procedures | 3 | 2015 | 1279 | 0.260 |
Why?
|
| Contracture | 1 | 2008 | 236 | 0.260 |
Why?
|
| Hallux | 2 | 2004 | 43 | 0.260 |
Why?
|
| Tissue Scaffolds | 2 | 2009 | 938 | 0.250 |
Why?
|
| Nails, Malformed | 1 | 2004 | 34 | 0.240 |
Why?
|
| Bone and Bones | 2 | 2020 | 2587 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5886 | 0.230 |
Why?
|
| Callosities | 1 | 2004 | 5 | 0.230 |
Why?
|
| Publishing | 1 | 2011 | 837 | 0.220 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1319 | 0.210 |
Why?
|
| Keratinocytes | 1 | 2007 | 876 | 0.210 |
Why?
|
| Soft Tissue Injuries | 1 | 2004 | 173 | 0.200 |
Why?
|
| Soft Tissue Infections | 1 | 2004 | 166 | 0.200 |
Why?
|
| External Fixators | 3 | 2009 | 99 | 0.190 |
Why?
|
| Arthrodesis | 3 | 2016 | 187 | 0.190 |
Why?
|
| Humans | 67 | 2023 | 767040 | 0.190 |
Why?
|
| Orthopedic Fixation Devices | 2 | 2009 | 76 | 0.180 |
Why?
|
| Materials Testing | 3 | 2008 | 870 | 0.180 |
Why?
|
| Range of Motion, Articular | 3 | 2018 | 1597 | 0.180 |
Why?
|
| Joint Instability | 3 | 2006 | 803 | 0.170 |
Why?
|
| Granulation Tissue | 1 | 2019 | 92 | 0.160 |
Why?
|
| Administration, Topical | 2 | 2011 | 703 | 0.160 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 3700 | 0.160 |
Why?
|
| Bone Wires | 2 | 2016 | 125 | 0.150 |
Why?
|
| Tendon Injuries | 2 | 2020 | 329 | 0.150 |
Why?
|
| Models, Structural | 1 | 1998 | 339 | 0.150 |
Why?
|
| Treatment Outcome | 13 | 2019 | 65295 | 0.150 |
Why?
|
| Cicatrix | 1 | 2004 | 798 | 0.150 |
Why?
|
| Pain | 1 | 2013 | 5101 | 0.140 |
Why?
|
| Ankle | 4 | 2011 | 353 | 0.140 |
Why?
|
| Weight-Bearing | 2 | 1997 | 532 | 0.140 |
Why?
|
| Osteoarthritis | 1 | 2005 | 1072 | 0.140 |
Why?
|
| Movement | 1 | 2003 | 1473 | 0.130 |
Why?
|
| Hammer Toe Syndrome | 1 | 2016 | 12 | 0.130 |
Why?
|
| Joint Prosthesis | 2 | 2016 | 251 | 0.130 |
Why?
|
| Casts, Surgical | 2 | 2009 | 184 | 0.130 |
Why?
|
| Ascorbic Acid | 1 | 1999 | 658 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15824 | 0.130 |
Why?
|
| Aged | 17 | 2023 | 171319 | 0.130 |
Why?
|
| Retrospective Studies | 11 | 2023 | 81659 | 0.130 |
Why?
|
| Pain Measurement | 3 | 2013 | 3584 | 0.130 |
Why?
|
| Lactates | 1 | 1995 | 398 | 0.120 |
Why?
|
| Polyglycolic Acid | 1 | 1995 | 406 | 0.110 |
Why?
|
| Bioengineering | 1 | 2014 | 99 | 0.110 |
Why?
|
| Bone Substitutes | 1 | 1995 | 230 | 0.110 |
Why?
|
| Radiography | 5 | 2009 | 6975 | 0.110 |
Why?
|
| Therapeutic Irrigation | 2 | 2011 | 297 | 0.110 |
Why?
|
| Follow-Up Studies | 7 | 2012 | 39317 | 0.100 |
Why?
|
| Severity of Illness Index | 4 | 2012 | 15925 | 0.100 |
Why?
|
| Male | 23 | 2018 | 364203 | 0.100 |
Why?
|
| Models, Animal | 1 | 2019 | 2121 | 0.100 |
Why?
|
| Guided Tissue Regeneration | 2 | 2009 | 86 | 0.100 |
Why?
|
| Hemoglobins | 1 | 2018 | 1531 | 0.100 |
Why?
|
| Female | 22 | 2018 | 396660 | 0.090 |
Why?
|
| Transplantation, Autologous | 1 | 2016 | 2118 | 0.090 |
Why?
|
| Prospective Studies | 9 | 2014 | 54886 | 0.090 |
Why?
|
| Adult | 19 | 2018 | 223317 | 0.090 |
Why?
|
| Middle Aged | 19 | 2018 | 223233 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 6310 | 0.090 |
Why?
|
| Disinfectants | 1 | 2011 | 131 | 0.090 |
Why?
|
| Lactic Acid | 1 | 1995 | 1139 | 0.080 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2010 | 488 | 0.080 |
Why?
|
| Walkers | 1 | 2009 | 3 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2015 | 640 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2010 | 254 | 0.080 |
Why?
|
| Pressure | 3 | 2007 | 1172 | 0.080 |
Why?
|
| Polymers | 1 | 1995 | 1624 | 0.070 |
Why?
|
| Tensile Strength | 1 | 2008 | 332 | 0.070 |
Why?
|
| Skin Ulcer | 1 | 2009 | 130 | 0.070 |
Why?
|
| Peer Review, Research | 1 | 2011 | 343 | 0.070 |
Why?
|
| Prostheses and Implants | 2 | 2009 | 1275 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 2 | 1999 | 1623 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2105 | 0.070 |
Why?
|
| Naphthalenes | 1 | 2007 | 198 | 0.060 |
Why?
|
| Endoscopy | 1 | 1996 | 1854 | 0.060 |
Why?
|
| Forefoot, Human | 1 | 2005 | 31 | 0.060 |
Why?
|
| Arthroplasty, Replacement | 1 | 2009 | 311 | 0.060 |
Why?
|
| Foot Deformities, Acquired | 1 | 2005 | 27 | 0.060 |
Why?
|
| Foot Bones | 1 | 2005 | 23 | 0.060 |
Why?
|
| Sesamoid Bones | 1 | 2005 | 14 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 4968 | 0.060 |
Why?
|
| Consensus | 1 | 2015 | 3207 | 0.060 |
Why?
|
| Medicare | 1 | 2023 | 6813 | 0.060 |
Why?
|
| Patient Care Team | 1 | 1996 | 2516 | 0.060 |
Why?
|
| Fractures, Spontaneous | 1 | 2006 | 232 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2011 | 8732 | 0.060 |
Why?
|
| Intraoperative Period | 1 | 2005 | 512 | 0.060 |
Why?
|
| Combined Modality Therapy | 3 | 2004 | 8535 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2011 | 4026 | 0.050 |
Why?
|
| Glycosylation | 2 | 1997 | 1099 | 0.050 |
Why?
|
| Joint Capsule | 1 | 2003 | 68 | 0.050 |
Why?
|
| Cadaver | 3 | 2009 | 1362 | 0.050 |
Why?
|
| Fibrin | 1 | 2006 | 514 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2015 | 3964 | 0.050 |
Why?
|
| Periosteum | 1 | 2003 | 139 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8048 | 0.050 |
Why?
|
| Microspheres | 1 | 2006 | 774 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2009 | 1441 | 0.050 |
Why?
|
| Amputation, Traumatic | 1 | 2004 | 135 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1997 | 3449 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 411 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 1673 | 0.050 |
Why?
|
| Sterilization | 2 | 2009 | 132 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 1733 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2007 | 760 | 0.050 |
Why?
|
| Young Adult | 4 | 2016 | 59980 | 0.050 |
Why?
|
| Osteogenesis, Distraction | 1 | 2004 | 233 | 0.050 |
Why?
|
| Postoperative Care | 2 | 2006 | 1480 | 0.050 |
Why?
|
| Equipment Design | 1 | 2009 | 3489 | 0.050 |
Why?
|
| Adolescent | 6 | 2016 | 89046 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6507 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2023 | 41718 | 0.040 |
Why?
|
| United States | 4 | 2023 | 72971 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2010 | 2780 | 0.040 |
Why?
|
| Skin Physiological Phenomena | 1 | 1999 | 193 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12451 | 0.040 |
Why?
|
| Mechanics | 1 | 1998 | 15 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 1999 | 1309 | 0.040 |
Why?
|
| Plastics | 1 | 1998 | 117 | 0.040 |
Why?
|
| Acute Disease | 2 | 2006 | 7236 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 12069 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2007 | 18989 | 0.030 |
Why?
|
| Electromagnetic Fields | 1 | 1998 | 290 | 0.030 |
Why?
|
| Elasticity | 1 | 1998 | 654 | 0.030 |
Why?
|
| Forecasting | 1 | 2005 | 2936 | 0.030 |
Why?
|
| Liposarcoma, Myxoid | 1 | 1995 | 60 | 0.030 |
Why?
|
| Connective Tissue | 1 | 1997 | 425 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2099 | 0.030 |
Why?
|
| Osseointegration | 1 | 2016 | 271 | 0.030 |
Why?
|
| Tuberculosis, Osteoarticular | 1 | 1994 | 26 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2007 | 10455 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 59548 | 0.030 |
Why?
|
| Patient Selection | 1 | 2006 | 4256 | 0.030 |
Why?
|
| Sprains and Strains | 1 | 1994 | 76 | 0.030 |
Why?
|
| Lateral Ligament, Ankle | 1 | 1994 | 57 | 0.030 |
Why?
|
| Polyesters | 1 | 1995 | 373 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7469 | 0.030 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1995 | 312 | 0.030 |
Why?
|
| Animals | 3 | 2019 | 168965 | 0.020 |
Why?
|
| Sample Size | 1 | 1995 | 845 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 1995 | 409 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 1992 | 318 | 0.020 |
Why?
|
| Surgical Staplers | 1 | 1991 | 34 | 0.020 |
Why?
|
| Awards and Prizes | 1 | 1995 | 365 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2006 | 9362 | 0.020 |
Why?
|
| Biophysics | 1 | 1992 | 376 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1995 | 706 | 0.020 |
Why?
|
| Ankle Injuries | 1 | 1994 | 339 | 0.020 |
Why?
|
| Models, Biological | 2 | 1996 | 9464 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2010 | 163 | 0.020 |
Why?
|
| Disease Progression | 1 | 2006 | 13646 | 0.020 |
Why?
|
| Bone Screws | 1 | 1992 | 533 | 0.020 |
Why?
|
| Research Design | 1 | 2003 | 6210 | 0.020 |
Why?
|
| Arthroscopy | 1 | 1994 | 971 | 0.020 |
Why?
|
| Angioplasty | 1 | 2010 | 355 | 0.020 |
Why?
|
| Limb Salvage | 1 | 2010 | 488 | 0.020 |
Why?
|
| San Francisco | 1 | 2007 | 166 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2009 | 381 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1995 | 1162 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 198 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2010 | 6000 | 0.020 |
Why?
|
| Risk Factors | 3 | 2007 | 74886 | 0.020 |
Why?
|
| Nails | 1 | 2007 | 298 | 0.010 |
Why?
|
| Debridement | 1 | 2007 | 494 | 0.010 |
Why?
|
| Physical Examination | 1 | 2010 | 1265 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 1429 | 0.010 |
Why?
|
| Methods | 1 | 2003 | 1065 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 2551 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 1368 | 0.010 |
Why?
|
| Orthopedics | 1 | 1991 | 906 | 0.010 |
Why?
|
| Oncolytic Viruses | 1 | 2006 | 344 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 20169 | 0.010 |
Why?
|
| Leg | 1 | 2005 | 1087 | 0.010 |
Why?
|
| Tibia | 1 | 2005 | 1075 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2007 | 1628 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2003 | 1824 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 1396 | 0.010 |
Why?
|
| Stents | 1 | 2010 | 3193 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2007 | 1547 | 0.010 |
Why?
|
| Quality of Life | 2 | 2016 | 13485 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 3488 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 5750 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14672 | 0.010 |
Why?
|
| Skin | 1 | 2009 | 4499 | 0.010 |
Why?
|
| Bone Regeneration | 1 | 1998 | 437 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2006 | 1665 | 0.010 |
Why?
|
| Silicones | 1 | 1995 | 228 | 0.010 |
Why?
|
| Boston | 1 | 2007 | 9360 | 0.010 |
Why?
|
| Rupture | 1 | 1994 | 444 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 15567 | 0.010 |
Why?
|
| Metals | 1 | 1995 | 711 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 7063 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 4282 | 0.000 |
Why?
|
| Life Expectancy | 1 | 1995 | 1248 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11657 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1994 | 1931 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1995 | 5537 | 0.000 |
Why?
|
| Age Factors | 1 | 1995 | 18401 | 0.000 |
Why?
|